Benefits of Aclidinium Persist to 1 Year for COPDBenefits of Aclidinium Persist to 1 Year for COPD

The long-acting muscarinic receptor antagonist aclidinium bromide continued to be effective for up to 52 weeks, according to the ACCORD COPD II extension study. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news